Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma

Malcolm S. Mitchell, Judith Abrams, John A. Thompson, Mohammed Kashani-Sabet, Ronald C. DeConti, Wen Jen Hwu, Michael B. Atkins, Eric Whitman, Marc S. Ernstoff, Frank G. Haluska, James G. Jakowatz, Tapas K. Das Gupta, Jon M. Richards, Wolfram E. Samlowski, John J. Costanzi, Frederick R. Aronson, Albert B. Deisseroth, Arkadiusz Z. Dudek, Vicky E. Jones

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences